| 05/14/2026 3:30 PM | Spyglass Pharma (1778922) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 03/26/2026 4:23 PM | Spyglass Pharma (1778922) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/17/2026 6:21 PM | RA CAPITAL MANAGEMENT, L.P. (1346824) Filed by Spyglass Pharma (1778922) Subject | Form SCHEDULE 13D | |
| 02/17/2026 6:23 PM | Samsara BioCapital, L.P. (1699737) Filed by Spyglass Pharma (1778922) Subject | Form SCHEDULE 13G | |
| 02/13/2026 5:21 PM | New Enterprise Associates 17, L.P. (1768564) Filed by Spyglass Pharma (1778922) Subject | Form SCHEDULE 13D | |
| 02/13/2026 3:01 PM | Spyglass Pharma (1778922) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/13/2026 10:36 AM | Sands Capital Life Sciences Pulse Fund III (0) DE Spyglass Pharma (1778922) Subject | Form SCHEDULE 13G | |
| 02/11/2026 4:13 PM | Nielsen Kirk G. (1523522) Reporting Spyglass Pharma (1778922) Issuer | Form 4/A | |
| 02/11/2026 4:15 PM | Kolchinsky Peter (1384859) Reporting RA Capital Healthcare Fund LP (1315082) Reporting RA CAPITAL MANAGEMENT, L.P. (1346824) Reporting RA Capital Nexus Fund III, L.P. (1883840) Reporting Shah Rajeev M. (1619841) Reporting Spyglass Pharma (1778922) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/10/2026 5:29 PM | Spyglass Pharma (1778922) Subject Vensana Capital I GP, LLC (1854073) Filed by | Form SCHEDULE 13D | |
| 02/10/2026 5:08 PM | Klein Peter Justin (1608710) Reporting Nielsen Kirk G. (1523522) Reporting Spyglass Pharma (1778922) Issuer Vensana Capital I GP, LLC (1854073) Reporting Vensana Capital I, L.P. (1757539) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for SGP and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Spyglass Pharma and its competitors with MarketBeat's FREE daily newsletter.
|
| 02/10/2026 5:09 PM | Nielsen Kirk G. (1523522) Reporting Spyglass Pharma (1778922) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/09/2026 3:39 PM | Mooney Patrick H. (2106886) Reporting Spyglass Pharma (1778922) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/09/2026 3:40 PM | Spyglass Pharma (1778922) Issuer Viret Jean-Frederic (1427569) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/09/2026 3:41 PM | Kahook Malik Y. (2106409) Reporting Spyglass Pharma (1778922) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/09/2026 3:42 PM | Pujara Chetan Pratap (2106897) Reporting Spyglass Pharma (1778922) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/09/2026 3:43 PM | Dennewill James Robert Jr. (2106895) Reporting Spyglass Pharma (1778922) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/09/2026 3:46 PM | O'Farrell Elizabeth G. (1744662) Reporting Spyglass Pharma (1778922) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/09/2026 3:47 PM | Dybbs Michael (1601264) Reporting Spyglass Pharma (1778922) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/09/2026 3:48 PM | Pardo Geoffrey B (1753143) Reporting Spyglass Pharma (1778922) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/09/2026 3:49 PM | Dable Habib J (1690773) Reporting Spyglass Pharma (1778922) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/09/2026 3:50 PM | Khan Bilal Arshad (2108044) Reporting Spyglass Pharma (1778922) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/09/2026 3:51 PM | Scheiner Zachary (1816523) Reporting Spyglass Pharma (1778922) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/06/2026 3:47 PM | Spyglass Pharma (1778922) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/05/2026 12:00 PM | Mooney Patrick H. (2106886) Reporting Spyglass Pharma (1778922) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/05/2026 12:01 PM | Kahook Malik Y. (2106409) Reporting Spyglass Pharma (1778922) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/05/2026 12:02 PM | Spyglass Pharma (1778922) Issuer Viret Jean-Frederic (1427569) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/05/2026 12:04 PM | Dennewill James Robert Jr. (2106895) Reporting Spyglass Pharma (1778922) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/05/2026 12:05 PM | Pujara Chetan Pratap (2106897) Reporting Spyglass Pharma (1778922) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/05/2026 12:06 PM | Khan Bilal Arshad (2108044) Reporting Spyglass Pharma (1778922) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/05/2026 12:07 PM | O'Farrell Elizabeth G. (1744662) Reporting Spyglass Pharma (1778922) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/05/2026 12:08 PM | Pardo Geoffrey B (1753143) Reporting Spyglass Pharma (1778922) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/05/2026 12:10 PM | Nielsen Kirk G. (1523522) Reporting Spyglass Pharma (1778922) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/05/2026 12:11 PM | Scheiner Zachary (1816523) Reporting Spyglass Pharma (1778922) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/05/2026 12:13 PM | Dybbs Michael (1601264) Reporting Spyglass Pharma (1778922) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/05/2026 12:14 PM | Dable Habib J (1690773) Reporting Spyglass Pharma (1778922) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 02/05/2026 10:36 AM | Spyglass Pharma (1778922) Filer | Form CERT | |
| 02/05/2026 9:47 AM | Spyglass Pharma (1778922) Filer | Form 8-A12B | |
| 02/01/2026 11:15 PM | Spyglass Pharma (1778922) Filer | Form EFFECT | |
| 01/16/2026 2:10 PM | Spyglass Pharma (1778922) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 06/05/2025 10:59 AM | Spyglass Pharma (1778922) Filer | Form D Notice of Exempt Offering of Securities | |
Elon Musk’s $1 Quadrillion AI IPO (Ad) $1 quadrillion would be enough to send a $2.8 million check to every man, woman, and child in America. That is the scale of what analysts are calling the biggest AI IPO in history.And right now, you can claim a stake before the company goes public, starting with just $500.Elon Musk is predicting this investment could climb 1,000x from here. Early access is available today. Claim Your Stake Now |